Cardiopulmonary Autotransfusion System Market

Cardiopulmonary Autotransfusion System is a sophisticated device with an exceptionally effective design that provides autologous blood during surgical procedures.

Autotransfusion is a process wherein a person receives their own blood for a transfusion, instead of banked allogenic (separate-donor) blood. There are two main kinds of Autotransfusion: Blood can be autologous "pre-donated" (termed so despite "donation" not typically referring to giving to one's self) before a surgery, or alternatively, it can be collected during and after the surgery using an intraoperative blood salvage device. The latter form of Autotransfusion is utilized in surgeries where there is expected a large volume blood loss.

Cardiopulmonary Autotransfusion System Market contains market size and forecasts of Cardiopulmonary Autotransfusion System in global, including the following market information:

Global Cardiopulmonary Autotransfusion System Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Cardiopulmonary Autotransfusion System Market Sales, 2017-2022, 2023-2028, (Units)

Global top five Cardiopulmonary Autotransfusion System companies in 2021 (%)

The global Cardiopulmonary Autotransfusion System market was valued at 569 million in 2021 and is projected to reach US$ 667 million by 2028, at a CAGR of 2.3% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Unwashed ATS Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Cardiopulmonary Autotransfusion System include Haemonetics, Medtronic, LivaNova, Fresenius Kabi, Terumo and Wandong Health Sources, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cardiopulmonary Autotransfusion System manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Cardiopulmonary Autotransfusion System Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Units)

Global Cardiopulmonary Autotransfusion System Market Segment Percentages, by Type, 2021 (%)

Unwashed ATS

Washed ATS

Global Cardiopulmonary Autotransfusion System Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Units)

Global Cardiopulmonary Autotransfusion System Market Segment Percentages, by Application, 2021 (%)

Heart Surgery

Great Organ Transplant Surgery

Other Surgery

Global Cardiopulmonary Autotransfusion System Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Units)

Global Cardiopulmonary Autotransfusion System Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Cardiopulmonary Autotransfusion System revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Cardiopulmonary Autotransfusion System revenues share in global market, 2021 (%)

Key companies Cardiopulmonary Autotransfusion System sales in global market, 2017-2022 (Estimated), (Units)

Key companies Cardiopulmonary Autotransfusion System sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Haemonetics

Medtronic

LivaNova

Fresenius Kabi

Terumo

Wandong Health Sources